NovaBay Pharmaceuticals, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
NBY on NYSE
Industry
Pharmaceutical Preparations
Location
2000 Powell Street, Suite 1150, Emeryville, CA

Insiders trading volume in the past year

NovaBay Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Poplar Point Capital Partners Lp 10%+ Owner $474K +$314K +195% Apr 2, 2025
Andrew D. Jones Cfo $231K Feb 15, 2023
Justin Hall CEO, GC and Director, Director $151K Sep 14, 2022
Paul E. Freiman Director $54.3K May 28, 2024
Mijia Wu Director $54.3K May 28, 2024
Yongxiang Zheng Director $54.3K May 28, 2024
Xinzhou Li Director, 10%+ Owner $54.3K May 21, 2021
Swan Sit Director $54.3K May 28, 2024
Yenyou Zheng Director $54.3K May 28, 2024
Julie Garlikov Director $54.3K May 28, 2024
David E. Lazar Chief Executive Officer, Director, 10%+ Owner $0 Aug 19, 2025
Jeffrey Kunin President, DERMAdoctor, LLC Dec 6, 2022
Audrey Kunin Chief Product Officer Dec 6, 2022
Tommy Law Interim CFO Feb 16, 2023

Recent Insider Transactions by Companies or Individuals for NovaBay Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.